We are live on
!
Find out more
JWBC
John W. Bristol & Co Portfolio holdings
AUM
$6.08B
1-Year Est. Return
16.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.1%
1 Year Est. Return
+16.51%
3 Year Est. Return
+77.29%
5 Year Est. Return
+103.39%
10 Year Est. Return
+452.38%
AUM
$3.46B
AUM Growth
+$57.9M
(+1.7%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
59
New
2
Increased
–
Reduced
48
Closed
2
Top Buys
| 1 |
TJX Companies
TJX
|
+$70.6M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$60.2M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$61.7M |
| 2 |
Walt Disney
DIS
|
+$46.9M |
| 3 |
PayPal
PYPL
|
+$24.8M |
| 4 |
Johnson & Johnson
JNJ
|
+$3.31M |
| 5 |
JPMorgan Chase
JPM
|
+$3.22M |
Sector Composition
| 1 | Financials | 16.89% |
| 2 | Healthcare | 16.63% |
| 3 | Technology | 13.35% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Industrials | 9.52% |
Similar funds
GA
EMPI
CDDEC
AA
HPG
EAM
CIS
HCM
John W. Bristol & Co's Q3 2017 Portfolio in Review
As of Q3 2017, John W. Bristol & Co held 59 positions worth $3.46B, up 1.7% from $3.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
John W. Bristol & Co's Q3 2017 filing shows 2 new, 48 reduced and 2 closed positions. Its largest new stake was TJX Companies: 1,981,336 shares worth $73M. The largest sale was Tiffany & Co., an estimated $61.7M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Technology.
- John W. Bristol & Co's largest Q3 2017 buy was TJX Companies: 1,981,336 shares worth $73M.
- John W. Bristol & Co's biggest Q3 2017 reduction was PayPal, cutting an estimated $24.8M.
- John W. Bristol & Co fully exited Tiffany & Co. in Q3 2017, selling an estimated $61.7M.
- John W. Bristol & Co's ten largest holdings make up 29% of its $3.46B portfolio in Q3 2017.
- John W. Bristol & Co opened 2 new positions and closed 2 in Q3 2017.
- John W. Bristol & Co's portfolio value rose 1.7% quarter-over-quarter to $3.46B.
Based on John W. Bristol & Co's 13F filing for Q3 2017, filed 13 Oct 2017.